KREBS BIOCHEMICALS & INDUSTRIES
Back to Income Statement
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹50 Cr | ₹52 Cr | ₹60 Cr | ₹54 Cr | ₹33 Cr |
What is the latest Revenue of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹52 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹54 Cr |
| Mar2021 | ₹33 Cr |
How is Revenue of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | -3.28 | |
| Mar2024 | ₹52 Cr | -12.68 | |
| Mar2023 | ₹60 Cr | 11.18 | |
| Mar2022 | ₹54 Cr | 60.72 | |
| Mar2021 | ₹33 Cr | - | |
Compare Revenue of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹128.3 Cr | -6.5% | -14.2% | -45.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,694.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,721.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,016.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹106,946.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,691.0 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | -6.5% |
-14.2% |
-45.9% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses